Susan Blackborough was just 12 when she was diagnosed with multiple sclerosis and was told she would lose her ability to walk ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

It’s one of the most surprising questions many women ask their doctors as they approach midlife: Does menopause bring any ...

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Studies in recent years have shown an that there is an increased incidence of multiple sclerosis among Black women.